For example, glial fibrillary acidic protein (GFAP) has more carbonylation sites in multiple sclerosis [2], Pick’s disease [3], and aging patients, but few in Alzheimer’s disease patients [4]. This evidence concerns the gene GFAP and frontotemporal dementia.